November/December 2013

Factors Associated With Employee Participation in a Value-Based Insurance Design Initiative

December 14, 2013

The American Journal of Pharmacy Benefits

We describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.

Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin

December 13, 2013

The American Journal of Pharmacy Benefits

Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.